Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma
NCT05322070: Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

Recruiting
4
125
US
Fluocinolone Acetonide Intravitreal Implant 0.18 mg, YUTIQ 0.18 mg
Alimera Sciences, CBCC Global Research
Uveitis, Posterior
11/25
11/25

Download Options